Biochemical aspects of arrhythmogenesis and ventricular fibrillation

Am J Cardiol. 1979 Jan;43(1):131-48. doi: 10.1016/0002-9149(79)90055-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Action Potentials
  • Adrenergic beta-Antagonists / therapeutic use
  • Animals
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / metabolism*
  • Arrhythmias, Cardiac / physiopathology
  • Bucladesine
  • Catecholamines / metabolism*
  • Catecholamines / physiology
  • Cyclic AMP / metabolism*
  • Cyclic AMP / physiology
  • Fatty Acids, Nonesterified / blood*
  • Glycolysis*
  • Humans
  • Hyperkalemia / complications
  • Lactates / blood*
  • Membrane Potentials
  • Myocardial Infarction / complications*
  • Myocardium / metabolism*
  • Potassium / metabolism*
  • Purkinje Fibers / physiopathology
  • Theophylline
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / metabolism*
  • Ventricular Fibrillation / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents
  • Catecholamines
  • Fatty Acids, Nonesterified
  • Lactates
  • Bucladesine
  • Theophylline
  • Cyclic AMP
  • Potassium